Bill To Ease Restrictions On Controlled Substance Exports Clears House Commerce Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Legislation that would remove certain export restrictions for controlled substances is now under review by the House Judiciary Committee. HR 184 would create “new parity” for U.S. pharmaceutical manufacturers, the bill’s sponsor says.